Novel proteins and nucleic acids encoding same
CA 2476691 A1 · Owner: Anderson, David W. · Inventors: Edinger, Shlomit R.; Li, Li; Dipippo, Vincent A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide polynucleotide or , antibody are disclosed as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically the , present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 3, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 3, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 3, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.